Anzeige
❌
Mehr »
Mittwoch, 11.11.2026 - Börsentäglich über 12.000 News
Nach dem KI-Boom kommt Quantum: Warum Anleger jetzt auf Delta Gold schauen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 881351 | ISIN: US68554V1089 | Ticker-Symbol: EP3
Tradegate
10.11.26 | 21:28
2,980 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ORASURE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ORASURE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,9603,04010:18
2,9803,02010:18

Aktuelle News zur ORASURE TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ORASURE TECHNOLOGIES Aktie jetzt für 0€ handeln
DiOraSure expects $30M-$32M Q4 revenue while shifting cash flow breakeven to H2 20271
MoOraSure Technologies Q3 2026 Earnings Call Transcript4
MoOraSure Technologies Non-GAAP EPS of -$0.15 beats by $0.03, revenue of $30.9M misses by $0.12M1
MoOraSure Technologies, Inc.: OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion1
MoORASURE TECHNOLOGIES INC - 10-Q, Quarterly Report-
02.11.OraSure Technologies, Inc.: OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care3
26.10.OraSure Technologies, Inc.: OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th1
06.09.OraSure (OSUR) Returns To Profit, But Growth Remains Elusive1
07.08.ORASURE TECHNOLOGIES INC - S-8, Securities to be offered to employees in employee benefit plans1
06.08.OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 20261
05.08.OraSure Technologies GAAP EPS of -$0.20 beats by $0.07, revenue of $30.64M beats by $1.58M1
05.08.OraSure Technologies, Inc.: OraSure Announces Second Quarter 2026 Financial Results183BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its...
► Artikel lesen
05.08.ORASURE TECHNOLOGIES INC - 8-K, Current Report1
04.08.OraSure Technologies Q2 2026 Earnings Preview-
22.07.OraSure Technologies, Inc.: OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th1
22.07.OraSure wins FDA emergency use nod for new Ebola test1
21.07.OraSure Technologies, Inc.: OraSure Receives Emergency Use Authorization for Second Generation Ebola Test356BETHLEHEM, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced...
► Artikel lesen
11.06.ORASURE TECHNOLOGIES INC - 8-K, Current Report2
11.06.OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient-Friendly Access to Testing for Sexually Transmitted Infections326BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure") (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced...
► Artikel lesen
03.06.ORASURE TECHNOLOGIES INC - 8-K, Current Report1
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1